Drug Product
Advanced Modalities
Company Overview
About
Mycenax Biotech Inc. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Taiwan
Founded:1992
Employees:1,040
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Global
International Regulatory
EU GMP Certificates
1
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval YXG47C
PMDA · #APR-G0HUVSBS · 2022-05-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-K0VSZVL7
Issued: 2020-08-25
Expires: 2025-01-11
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-BWPEW6NO
Issued: 2020-02-26
Expires: 2025-09-25
Loading CDMO intelligence...
Key facts about Mycenax Biotech Inc.
- Mycenax Biotech Inc. is headquartered in Taiwan.
- Mycenax Biotech Inc. was founded in 1992.
- Mycenax Biotech Inc. has 1,040 employees.
- Mycenax Biotech Inc.'s capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Mycenax Biotech Inc.
Directory pages this company appears in, each with the full list of matching manufacturers.